Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Journal Scan / Research · October 21, 2020

Availability, Clinical Testing, and US FDA Review of Biosimilar Biologic Products

JAMA Internal Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Internal Medicine
Assessment of Availability, Clinical Testing, and US Food and Drug Administration Review of Biosimilar Biologic Products
JAMA Intern Med 2020 Oct 05;[EPub Ahead of Print], TJ Moore, MC Mouslim, JL Blunt, GC Alexander, KM Shermock

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading